Clinical Trial Update: Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa... [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II randomized trial evaluating PfSPZ-CVac malaria vaccination with pyrimethamine or chloroquine chemoprophylaxis; completed with posted results in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Chloroquine (chloroquine)
• PfSPZ-CVac (PfSPZ-CVac)
• Pyrimethamine (Pyrimethamine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-07-12